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Habitual Intravenous Drug Use and the Connection to Self-Medication in the Missoula 
Country Area 
Faculty Mentor: Annie Sondag  
According to the National Alliance on Mental Illness (NAMI) about one-third of people 
living with mental illness in the US also experience substance abuse. It’s becoming 
apparent that dual diagnosis is common in our nation. The National Institute on Drug 
Abuse (NIDA) insists that one doesn’t simply cause the other.  
The purpose of this study is twofold.  First, to examine the relationship between mental 
illness and intravenous drug use as self-medication among clients visiting the non-profit, 
Open AID Alliance (OAA), in Missoula, MT. Second, to explore the barriers to seeking 
mental health care among intravenous drug users who report mental health issues.   
This descriptive study will use a quantitative approach to data collection. Quantitative data 
will be collected via a Qualtrics survey containing six questions inquiring about drug use 
and mental health self-medication. Participant recruitment will take place at OAA where 
individuals visiting the syringe exchange program will be invited to volunteer for the study. 
Volunteers will be provided an electronic tablet upon which they can link to and complete 
the survey. Once submitted to the Qualtrics platform, the responses will be anonymous. 
Quantitative data will be analyzed descriptively and will include frequencies, means and 
cross-tabulation calculations. Charts and graphs will be used to display data.  
The results from this study will provide staff at OAA an estimate of how many intravenous 
drug users accessing their services suffer from mental illness, diagnosed or undiagnosed. 
It will allow OAA to evaluate their clients’ barriers to mental health support. Further, it will 
allow them to address these barriers with their clients and assist them in accessing 
services. Hopefully, results from this study will encourage some of Missoula’s mental 
health support systems to enhance their outreach to the intravenous drug community. 
Habitual Intravenous Drug Use and the Connection to Self-Medication in the Missoula 
County Area  
Literature on Drug Abuse as Self-Medication and Comorbidity 
According to the National Alliance on Mental Illness (NAMI), about one-third of 
people living with mental illness also experience substance abuse. NAMI also reported 
that when specifically looking at the United States’ drug abuse community, about one-half 
of those individuals experience mental illness (National Alliance, n.d). The National 
Institute on Drug Abuse (NIDA) makes it clear that one doesn’t simply cause the other. In 
some cases, drug use leads to mental illness. In others, it’s mental illness that leads to 
drug use. The NIDA has found that since mood disorders increase vulnerability to drug 
abuse and addiction, the treatment of mental illness can result in lowered drug use, 
especially in the cases of self-medication (National Alliance, n.d). Research in Montana 
pertaining to the comorbidity (the simultaneous presence of two chronic diseases in the 
same patient) of drug addiction and mental illness is scarce. Knowledge pertaining to 
drug abuse and its relationship with mental illness is still in the early processes of 
discovery.  
Nora Volkow did an assessment of various studies on comorbidity in 2001. She 
highlighted that while the definition of comorbidity is becoming well understood, the 
mechanisms of mental illness and drug abuse and the influence drugs have on mental 
illness is still poorly understood (Volkow, 2001). A critical question that remains 
unanswered is why the abuse of drugs appears to trigger mental illness in users with no 
previous mental health history (Volkow, 2001). Volkow discussed that stress disorders 
(PTSD, anxiety, etc) have symptoms that can be momentarily self-medicated by the 
injection and use of different drugs. However, many drug’s withdrawal periods can 
interrupt the body’s natural responses to stress based mental illness symptoms, thus 
reinforcing continued self-medication through injection drugs. Drug abuse and stress 
disorders also both activate the same stress circuits in the brain, so they affect our body 
systems synergistically (Volkow, 2001).  
Another study, conducted by Drake and Wallach (1989), examined 187 chronic 
mentally ill individuals and analyzed their success in society. About one-third of those 187 
individuals abused street drugs (heroin, meth, cocaine etc). Patients who were diagnosed 
with the comorbidity of drug abuse and mental illness were, on average, younger and less 
able to manage their personal lives among their communities. They lacked food 
resources and adequate finances while also having higher incidences of hostility and 
suicidal thoughts. If the individuals were utilizing mental health support, they tended to be 
found as noncompliant with the services.  
Grove et al. (1979) analyzed the relationship of drug use and the mental health of 
young addicts aged 18-29. The study found that many users identified some of their use 
as a way to temporarily alleviate mental health symptoms and to enable them to function 
properly. The study found however, that the young addicts viewed their drug use as an 
overall positive influence on their lives. They tended to over report the benefits of their 
drug use and under report the costs when asked deliberate questions about their injection 
habits. It was also found that a large number of those surveyed occasionally used drugs 
consciously as a coping strategy for depression like symptoms. The perception that drug 
use can increase one’s mental health status was shown as a strong motivator for  young 
addicts to continue their use (Grove et al., 1979). A final finding of the study was the 
discovery of a strong positive correlation between increased drug use and decreased 
mental status. Conclusively, this study found that heavy drug use reflects an attempt to 
cope with psychological problems. Grove et al. (1979) speculates that the societal and 
interpersonal stressors are motivating factors for addicts to inject drugs with 
pharmacological properties that help them cope. This allows a potential cycle to exist, 
where drugs are injected to alleviate stress, but later the withdrawal symptoms contribute 
to added stress, leading to more drug injection (Grove et al., 1979).  
Research pertaining to the comorbidity of mental illness and illicit drug abuse is 
limited at the national level, especially for those living with medically undiagnosed mental 
illnesses. More so, due to a lack of awareness around the issue, and a heightened stigma 
towards drug use in Montana, state research surrounding this topic is currently 
inconclusive. “The Behavioral Health Barometer of Montana” report was conducted in 
2015 and offers a snapshot of mental illness and drug abuse in Montana. However, there 
is no cross-referencing of those two variables in this report. For reference, in 2013-2014, 
4.7% (36,000) of adults in Montana had been diagnosed with a serious mental illness 
(SMI). An SMI is defined by the Substance Abuse and Mental Health Services 
Administration (SAMHSA) as “adults aged 18 or older who currently or at any time in the 
past year have had a diagnosable mental, behavioral, or emotional disorder (excluding 
developmental and substance use disorders) of sufficient duration to meet diagnostic 
criteria specified within the DSM-IV that has resulted in serious functional impairment, 
which substantially interferes with or limits one or more major life activities” (Substance, 
2015). Of those 36,000 people, 52.5% of them had not received mental health support or 
counseling (Substance, 2015). For illicit drug abuse, 2.1% (18,000) of persons aged 12 or 
older were dependent on or abusing illicit drugs. Ninety-three percent of those individuals 
had never received treatment for their drug addiction. ‘Treatment’ is referring to hospital 
(inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency 
room, private doctor’s office, self-help group, or prison/jail (Substance, 2015).    
The NIDA also conducted a couple different studies looking at common barriers to 
treating the comorbidity of drug abuse and mental illness in the US. There is a lot of 
background research currently supporting the claim that comorbid conditions need to be 
treated concurrently (National Institute, n.d). However, mental health care systems and 
substance abuse treatment and support systems are overall disconnected from each 
other. Furthermore, different insurance providers don’t cover the same types of treatment, 
making treatment of both occasionally impossible (National Institute, n.d).  Many drug 
users identify the existence of  a stigma against them at mental health focused support 
centers (National Institute, n.d). Health providers also tend to understand how to treat 
mental illnesses but don’t have proper training on how to treat substance abuse disorders 
(National Institute, n.d). When considering solely substance abuse treatment centers, a 
lot of the workers are biased against using any medications to treat for mental illness, 
including those proven to be helpful for mood/anxiety disorders. One final barrier to 
comorbid treatment centers is that many of those who need treatment cannot access it 
because they are in the criminal justice system (National Institute, n.d).  
Purpose of the Study 
 The purpose of this study is to examine the relationship between mental illness, 
diagnosed or undiagnosed, and intravenous drug use as self-medication among people 
who inject drugs (PWID) in the Missoula area. Nationwide, it is understood that 
comorbidity is common between mental illness, especially stress disorders, and illicit drug 
addiction. However, very little consideration has been focused on this topic in the state of 
Montana. For PWID, the assumption is that many are consciously suffering from mental 
illness and potentially living their lives undiagnosed without any treatment. This study 
planned to explore whether or not PWID in the Missoula area are suffering from mental 
illness based on their own self-reflection. The next goal was to determine whether or not 
those surveyed, on their own reflection, are injecting drugs to, at least partially, cope with 
mental illness symptoms. Furthermore, the study sought to determine if PWID in the 
Missoula area have reached out to obtain mental health care and to determine their 
barriers to those services.   
Importance of the Study 
 Results from this study will give Open Aid Alliance (OAA), a nonprofit that works 
closely with PWID in the Missoula area, an idea of how many intravenous drug users 
utilizing their services suffer from mental illness, diagnosed or undiagnosed. Furthermore, 
it will shed light on the potential that those suffering with the comorbidity of mental illness 
and substance addiction are furthering their addiction by injecting drugs to alleviate their 
symptoms. It will educate those working with PWID in Missoula that there is a possibility 
that many of them are stuck in the ‘cycle’ referenced by Grove et al (1979). OAA will also 
get a snapshot of their clients’ barriers to mental health support and will have the 
opportunity to address those barriers and assist their clients in getting the mental health 
services they need. OAA will be able to evaluate if their outreach to mental health 
services in Missoula needs to be improved to help increase the percentage of PWIDs 
using those services. 
  
   Methods and Procedures 
 This project utilized an electronic survey to collect quantitative data surrounding 
mental illness and the injection of drugs as self-medication. The survey was created using 
Qualtrics Survey Software and was designed to gather data about the PWID community 
of Missoula. This system was chosen because it utilizes high firewall and security scans 
on a regular basis. Qualtrics also uses Transport Layer Security (TLS) encryption for any 
data entered into the program. This allowed for the high degree protection of the entered 
data. This level of security was essential for this study since the data was taken from a 
vulnerable population that is also commonly associated with paranoia towards data 
collection. 
 The study took place at Missoula Open Aid Alliance. Many members of the drug 
injection community in Missoula use the syringe exchange program(SEP) at OAA on a 
weekly basis. A SEP is defined by the CDC as  
“community-based programs that provide access to sterile needles and 
syringes free of cost and facilitate safe disposal of used needles and 
syringes. As described in the CDC and U.S. Department of Health and 
Human Services (HHS) guidance, SEPs are an effective component of a 
comprehensive, integrated approach to HIV prevention among PWID. 
These programs have also been associated with reduced risk for infection 
with hepatitis C virus. Most SEPs offer other prevention materials (e.g., 
alcohol swabs, vials of sterile water, condoms) and services, such as 
education on safer injection practices and wound care; overdose prevention; 
referral to substance use disorder treatment programs including medication-
assisted treatment; and counseling and testing for HIV and Hep 
C” (Centers, n.d).      
The only identifiers taken from the volunteers were age and gender, so HIPPA 
didn’t play a role in this specific study. 
Survey Development 
The survey was written to explore whether Missoula’s PWID population was 
suffering from mental illness, and if symptoms contributed to their injection drug use. 
Further, the survey sought  to determine if this population was reaching out to mental 
health support and their barriers to that support. (see Appendix A) 
 The survey consisted of six questions. Several of the questions used a filtering 
system. If a volunteer identified as having a mental illness for question 3, they proceeded 
to question 4. If their response was ‘none’ they were directed to question 6. This was to 
direct survey responses about mental illness and drug injection to only user’s who 
identified as having a mental illness. However, the filtering still allowed the study to look at 
their barriers to mental health support in case they’d considered support in the past. A 
similar process was set for question 4, where a ‘yes’ response continued the survey to 
question 5, and a ‘no’ directed the volunteer to question 6. This was to improve the 
survey’s flow while allowing the survey to gather information about mental health barriers 
for all drug users in Missoula, not just those self-medicating via injection. For Question 5, 
if a user answered ‘yes’, they were directed to the end of the survey and a ‘no’ directed 
them to question 6. This was to eliminate users who had successfully used Missoula’s 
mental health systems from the question pertaining to barriers towards the accessibility of 
those systems. Question 3 and question 6 allowed participants to check multiple 
responses.  
Participant Recruitment 
The recruitment of volunteers for the survey was straightforward and limited to 
clients of the syringe exchange program at OAA. When an injection drug user entered the 
SEP at OAA, they would fully go through the exchange process. Their dirty needles would 
be disposed of in exchange for clean ones, harm reduction supplies would be offered, 
referral services would be explained and they would be ready to leave the exchange with 
all questions answered. Once the formalities of the exchange were complete, the client 
would be asked if they were interested in participating in an anonymous survey that I, the 
needle exchanger, was conducting for the University of Montana’s honors college. To gain 
consent, the details about the project and their rights as a volunteer were read to them. 
(see Appendix B) 
Upon consent, volunteers read six questions from the survey in the private SEP 
area at OAA and the volunteer answered each question to the best of their ability. When 
the survey was complete, each volunteer was asked if they required any other assistance 
from the SEP and thanked for contributing to the project’s research. Each survey 
submission took approximately 5 minutes. There was no compensation for volunteering, 
however every volunteer was informed at the end of the survey about how their 
submission would help further OAA’s knowledge base surrounding their clients and in the 
end help them improve their resources for Missoula’s PWID population.  
Results 
 Frequencies and percentages were calculated for each question topic posed by 
the survey: age, gender, mental illness, the use of injection to cope with symptoms, the 
use of mental health support systems, and barriers to accessing those systems. Due to 
the filtering system in place for the survey, a couple of the questions saw a slight drop in 
the number surveyed depending on specific answers given by volunteers to previous 
questions.  
Participant Demographics 
 Twenty-four volunteers completed the survey.  Eleven (45.83%) were between the 
age of 31-40 and five (20.83%) were between the age of 41-50. Six (25%) of the 
surveyed population were aged 18-30. A near even split was found between gender, with 
13 (54.17%) respondents identifying as female and 11 (45.83%) identifying as male.  
Mental Illness 
Nearly two-thirds of the participants reported suffering from depression and nearly 
half reported suffering from anxiety.  Only four of the 24 participants reported no mental 
illness. The results for mental illnesses listed on the survey, whether self or medically 
diagnosed, can be found below in Figure 1.  
Count of Volunteers Identifying with Listed Mental Illnesses    
Figure 1 
 Of the 20 volunteers who identified as suffering from mental illness, nearly three-
quarters of them (n=15) said they inject drugs to cope with symptoms of those illnesses. 
Two-thirds (n=10) of the individuals who reported injecting drugs to cope with mental 
illnesses also reported previously seeking out mental health support in Missoula.  
Most volunteers who had previously reached out to mental health support 
expressed signs of dissatisfaction with their experiences. To analyze why some 
volunteers were displeased with mental health support or why they never reached out to 
any services at all, the survey explored common barriers to seeking mental health 
services in Missoula.  
Counts of Volunteers Identifying Barriers to Mental Health Support in Missoula 
Figure 2 
Due to the filtering process of the survey described in the methods section, only 14 
out of the 24 respondents answered the 6th question pertaining to barriers to mental 
health services in Missoula. Four of the 14 volunteers said they were not currently 
struggling with mental health issues. Five did not believe their drug use was related to 
coping with their identified mental illnesses. The other 5 volunteers were suffering from 
mental illness, injecting to cope with symptoms and had never before successfully 
reached out to mental health services. 
The three most common barriers to mental health support in Missoula were; 1) 
“believing that mental health staff would not understand them or their drug use” (n=4); 2) 
“believing they could handle symptoms on their own” (n=3);  and 3) “having no health 
coverage/being unable to afford the cost” (n=3). Figure 2 (see above) shows the 
breakdown of the barriers identified by 14 volunteers. 
Three users identified having successfully used mental health support in the past 
(21.43%) and, cross tabulation revealed that those three of users also didn’t identify their 
drug use as a coping mechanism for their mental illnesses.  
Discussion 
 The connection between mental illness and substance abuse has been clearly 
established in the literature. The National Institutes of Drug abuse (NIDA) found that when 
compared to the general U.S population, those diagnosed with mood or anxiety disorders 
are twice as likely to also suffer from a drug abuse disorder. Volkow (2001) studied how 
stress disorders have symptoms that are easily mediated by the injection of different 
drugs. However, she discovered that withdrawal symptoms also tend to interrupt our 
bodies natural ability to cope with stress, thus reinforcing drugs as self-medication.       
 While it is not possible to establish cause and effect in regard to mental illness and 
substance abuse, the results from this study clearly support the belief that many people 
who use injection drugs do so because they perceive that the drugs help them cope with 
a mental illness. For the majority of people in this study, mental health issues such as 
depression and anxiety were the most frequently reported, while other less frequently 
reported mental illnesses included PTSD and bipolar disorder. With anxiety and 
depression being the top choices of the participants in this study, and all participants 
being regular intravenous drug users, the results reinforced the findings of the NIDA that 
drug abuse is extremely common among those suffering with mood/anxiety disorders. 
This study contributed evidence to the proposition that the NIDA’s belief about 
comorbidity also exists in the PWID sub-community of Missoula, MT.   
 Three-quarters of this study’s participants who identified as suffering from mental 
illness also consciously identified their injection drug use as a coping strategy for mood/
anxiety disorder symptoms. This supports the belief identified by Grove et al. (1979) that 
drug injection may be regarded as a positive aspect of the user’s life if it helps alleviate 
mood/anxiety disorder symptoms. This potential positive effect of the drug injection may 
be affecting the likelihood that one will continue to inject drugs as long as they suffer from 
mental illness symptoms. To reiterate, the comorbidity cycle, identified by Grove et al, 
describes external life stressors and the stressors of mental illness inducing increased 
drug injection to cope. That drug injection then increases one’s external stressors and 
resets the cycle. The use of injection drugs to cope with mental illness symptoms found in 
this study confirms that the cycle exists within the Missoula drug injection population as 
well.  
 Alleviating mental illness symptoms with injection drugs has been shown to 
reinforce the desire to inject said drugs, and three-quarters of injection drug users 
suffering from mental illness in this study inject as a coping mechanism. This study 
inferred that treating for mental illness with other, more traditional outlets, may decrease 
the frequency of drug injection among PWID in Missoula. Two-thirds of those injecting 
drugs to cope with mental illness said they’d reached out previously to mental health 
support. However only three out of the 14 volunteers who identified barriers to mental 
health support said they’d successfully used mental health services in Missoula. Many 
individuals in this study did not seek mental health care because of their inability to pay 
for services or their fear of being misunderstood by health care providers. The individuals 
who were able to access services also reported overall negative experiences with 
healthcare providers in Missoula.  
 The NIDA found that some of the most common barriers to treatment for mental 
health and drug abuse in the US were health care providers being untrained at treating 
those suffering from drug abuse and mental illness, the unlikelihood for insurance 
companies to cover comorbid treatments, and substance abuse treatment centers being 
biased towards not prescribing medications for mental illness. The results of this study 
suggest that the PWID population in Missoula is struggling with similar barriers identified 
nationally by the NIDA, including the cost of treatment and a lack of understanding 
between drug users and health care workers. These conclusions suggest that the 
Missoula community needs to address these barriers and work towards solutions to help 
the drug injection population.   
  
Limitations 
 This study offers insights to the local community regarding the relationship 
between injection drug abuse and mental health issues, however, the findings should be 
interpreted in light of the following limitations.  First, the sample recruited for this study 
was not randomly selected. Any individual who entered the syringe exchange at OAA 
while the researcher was present (usually Tuesdays or Thursdays) was asked to 
volunteer to participate in this study. Those included were any injection drug users who 
consented to fill out the survey after utilizing the SEP’s services, so the sample was 
recruited through convenience for the researcher. Second, this study relied on the 
volunteers’ self-perceptions of mental illness. There was no requirement for individuals to 
be medically diagnosed with mental illness to participate, they were just asked to report if 
they thought they were suffering from mental illness symptoms. Third, there was no 
clarification regarding whether the volunteers identified their drug use to be solely a 
coping mechanism for mental illness symptoms or only partially. Fourth, this study had a 
very small sample size and makes conclusions derived from the survey difficult to 
generalize to the entire Missoula PWID population. 
Recommendations 
 Given the high percentage of volunteers in this study that reported a connection 
between their drug abuse and mental health issues, and the many identified barriers to 
treatment in Missoula, the researcher recommends the following actions: 
1.) Open Aid Alliance should address and report to the Missoula City-County Public 
Health Department the comorbidity prevalence in this sample of PWID population and the 
high frequency with which PWID use injection drugs as self-medication for mental 
illnesses.. Hopefully by bringing these issues to the Health Department’s attention, 
funding and planning for improving the Missoula PWID sub-community’s access to mental 
health support systems would become a focus.  
2.)  Open Aid Alliance should expand their community outreach efforts to Missoula health 
care centers like walk-in clinics (CostCare etc) or Partnership Health Center and educate 
them on the importance of recognizing and treating for the comorbidity of drug abuse and 
mental illness. This will hopefully decrease the existing stigmas towards drug users that 
create barriers to them accessing mental health support. 
3.) Ultimately, OAA and other organizations that serve PWID should seek policy/
legislation that would increase access to mental health services. 
Conclusions 
 Clearly, a majority of individuals who are using injection drugs also suffer from 
mental illness. Furthermore, a substantial number of injection drug users report using 
drugs to self-medicate against the negative effects of their mental illness. The presence of 
comorbidity of drug abuse and mental illness nationwide has been established as 
common knowledge and now, this study provides evidence that comorbidity is a serious 
issue effecting the PWID population of Missoula as well. Rather than treating people who 
abuse substances as criminals, the Missoula community, and the nation as a whole, 
needs to start evaluating substance abuse as a disease that is potentially being 
reinforced by the suffering caused by underlying mental illness. We need to understand 
that many users are injecting to cope with mental health symptoms that could be treated 
in different ways. We need to analyze if treating drug users mental health illnesses 
through clinics and support systems could help them rely less on injection drugs. If these 
conclusions are valid, treatment could potentially lower the overall frequency of injection 
drugs in the Missoula population.  
 To help the PWID population access that treatment, health care professionals need 
to be trained to help treat substance abuse as well as mental illness so the negative 
stigma felt by drug users can be reduced. We also need to continue to evaluate our 
insurance and health care programs and address why this population has a hard time 
affording mental health care support. When we start viewing drug addiction as an illness 
and not a flaw, and care for the healing of others instead of the proliferation of stigmas, 
we can begin to see a population that really needs the support of their communities. The 
Missoula community could make a huge difference in the lives of those struggling with 
mental illness and drug abuse if we could just take some small steps to improve their 
access to mental health support.   
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Appendix A: Survey 
  














Ο Bipolar Disorder 
Ο Panic Disorder 
Ο Other Mental Health Struggles (please specify)_________________________________ 
Ο None 
4.) By your own self-reflection, are you injecting to cope with any mental illness symptoms? 
Ο Yes 
Ο No 
5.) If yes to self-medicating (using drugs to cope with symptoms), have you ever sought out mental 
health support?  
Ο Yes 
Ο No 
6.) If you’ve considered mental health support but never reached out, why not?  
Ο No health coverage/can’t afford the cost 
Ο Unaware of options of where to go for support 
Ο Believe that support will not understand them or their use 
Ο Afraid that treatment will cause members of community/ family to have a negative opinion 
Ο Handling symptoms on own 
Ο No transportation/inconvenient 
Ο I’ve successfully used mental health support 
Ο Other barriers to reaching out for help (please specify) ____________________________ 
Ο non applicable  
Appendix B: Consent Script 
Verbal Script for In-Person Consent  
● Would you be willing to take some time today to volunteer and participate in a research 
project for my honors thesis at the University of Montana? 
● If you agree to participate, the survey will only take about 5 minutes, and consists of 6 
questions. 
● The survey is completely anonymous, only for persons aged 18 or older, and no 
personal identifiers will be recorded.  
● he data will be entered into a survey system called Qualtrics where all data is greatly 
protected. 
● The analyzed data will be presented to the University of Montana at an undergraduate 
research conference, but individual answers to questions will be kept completely 
private and anonymous. 
● The survey is completely voluntary, and you can skip any questions you don’t want to 
answer. 
● You can also quit taking the survey at any time, and leave with no consequences. 
● Hopefully this research project will help expand Open Aid Alliance’s knowledge about 
drug use and self-medication for mental illness to further help the drug community of 
Missoula.  
● If you have any further questions about this survey, please ask me, Meaghan Gaul, at 
any time or call Open Aid Alliance at (406-543-4770)
